1. Home
  2. MLEC vs RNXT Comparison

MLEC vs RNXT Comparison

Compare MLEC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • RNXT
  • Stock Information
  • Founded
  • MLEC 2008
  • RNXT 2012
  • Country
  • MLEC United Kingdom
  • RNXT United States
  • Employees
  • MLEC N/A
  • RNXT N/A
  • Industry
  • MLEC Blank Checks
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLEC Finance
  • RNXT Health Care
  • Exchange
  • MLEC Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • MLEC 36.0M
  • RNXT 44.6M
  • IPO Year
  • MLEC N/A
  • RNXT 2021
  • Fundamental
  • Price
  • MLEC $5.37
  • RNXT $1.30
  • Analyst Decision
  • MLEC
  • RNXT Strong Buy
  • Analyst Count
  • MLEC 0
  • RNXT 2
  • Target Price
  • MLEC N/A
  • RNXT $7.25
  • AVG Volume (30 Days)
  • MLEC 15.9K
  • RNXT 135.9K
  • Earning Date
  • MLEC 07-22-2025
  • RNXT 08-12-2025
  • Dividend Yield
  • MLEC N/A
  • RNXT N/A
  • EPS Growth
  • MLEC N/A
  • RNXT N/A
  • EPS
  • MLEC N/A
  • RNXT N/A
  • Revenue
  • MLEC N/A
  • RNXT $240,000.00
  • Revenue This Year
  • MLEC $20.42
  • RNXT $3,104.65
  • Revenue Next Year
  • MLEC $30.00
  • RNXT $301.89
  • P/E Ratio
  • MLEC N/A
  • RNXT N/A
  • Revenue Growth
  • MLEC 170.36
  • RNXT N/A
  • 52 Week Low
  • MLEC $4.60
  • RNXT $0.75
  • 52 Week High
  • MLEC $10.90
  • RNXT $1.69
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 32.37
  • RNXT 53.41
  • Support Level
  • MLEC $5.63
  • RNXT $1.29
  • Resistance Level
  • MLEC $5.88
  • RNXT $1.38
  • Average True Range (ATR)
  • MLEC 0.54
  • RNXT 0.07
  • MACD
  • MLEC -0.11
  • RNXT -0.01
  • Stochastic Oscillator
  • MLEC 22.54
  • RNXT 48.39

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: